Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy Study of Rapamycin- and Zotarolimus-Eluting Stents to Reduce Coronary Restenosis (ISAR-TEST-5)
This study is currently recruiting participants.
Study NCT00598533   Information provided by Deutsches Herzzentrum Muenchen
First Received: January 10, 2008   Last Updated: January 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Heart Disease
Additional conditions recognized in this trial
Coronary Artery Disease
Coronary Disease
Coronary Restenosis
Heart Diseases
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Coronary Stenosis
Myocardial Ischemia
Vascular Diseases
Additional drug interventions recognized in this trial
Probucol
Sirolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Anticholesteremic Agents
Antifungal Agents
Antilipemic Agents
Antimetabolites
Antineoplastic Agents
Antioxidants
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Deutsches Herzzentrum Muenchen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services